Lehrer S - Search Results

1

ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.

Cesaretti JA, Stock RG, Lehrer S, Atencio DA, Bernstein JL, Stone NN, Wallenstein S, Green S, Loeb K, Kollmeier M, Smith M, Rosenstein BS. Cesaretti JA, et al. Among authors: lehrer s. Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):196-202. doi: 10.1016/j.ijrobp.2004.09.031. Int J Radiat Oncol Biol Phys. 2005. PMID: 15629612

2

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.

Lehrer S, Fodor F, Stock RG, Stone NN, Eng C, Song HK, McGovern M. Lehrer S, et al. Br J Cancer. 1998 Sep;78(6):771-3. doi: 10.1038/bjc.1998.576. Br J Cancer. 1998. PMID: 9743298 Free PMC article.

3

Body mass, age, and the APC I1307K allele in Ashkenazi Jewish prostate cancer patients.

Lehrer S, McCurdy LD, Stock RG, Kornreich R, Stone NN, Eng C. Lehrer S, et al. Cancer Genet Cytogenet. 2000 Oct 15;122(2):131-3. doi: 10.1016/s0165-4608(00)00291-0. Cancer Genet Cytogenet. 2000. PMID: 11106824

4

Increased serum insulin associated with increased risk of prostate cancer recurrence.

Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Lehrer S, et al. Prostate. 2002 Jan 1;50(1):1-3. doi: 10.1002/pros.10026. Prostate. 2002. PMID: 11757030

5

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.

Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG. Lehrer S, et al. Br J Cancer. 2002 Sep 23;87(7):726-8. doi: 10.1038/sj.bjc.6600526. Br J Cancer. 2002. PMID: 12232754 Free PMC article.

6

Serum triiodothyronine is increased in men with prostate cancer and benign prostatic hyperplasia.

Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG. Lehrer S, et al. J Urol. 2002 Dec;168(6):2431-3. doi: 10.1016/S0022-5347(05)64161-4. J Urol. 2002. PMID: 12441933

7

Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer.

Lehrer S, Stone NN, Droller MJ, Stock RG. Lehrer S, et al. Urol Oncol. 2002 Mar-Apr;7(2):73-6. doi: 10.1016/s1078-1439(01)00155-7. Urol Oncol. 2002. PMID: 12474526

8

Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

Lehrer S, Diamond EJ, Droller MJ, Stone NN, Stock RG. Lehrer S, et al. J Natl Cancer Inst. 2002 Dec 18;94(24):1893; author reply 1893-4. doi: 10.1093/jnci/94.24.1893. J Natl Cancer Inst. 2002. PMID: 12488486 No abstract available.

9

Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer.

Lehrer S, Diamond EJ, Bajwa AM, Kornreich R, Stagger S, Stone NN, Droller MJ, Stock RG. Lehrer S, et al. Prostate Cancer Prostatic Dis. 2001;4(4):232-234. doi: 10.1038/sj.pcan.4500542. Prostate Cancer Prostatic Dis. 2001. PMID: 12497024

10

Elevated serum triiodothyronine (t3) in Ashkenazi Jewish prostate cancer patients carrying the I1307k allele of the APC (adenopolyposis coli) gene.

Lehrer S, Diamond EJ, Stone NN, Droller MJ, Stock RG, Stone M, Bajwa A, Kornreich R. Lehrer S, et al. Urol Oncol. 2003 Mar-Apr;21(2):101-4. doi: 10.1016/s1078-1439(02)00210-7. Urol Oncol. 2003. PMID: 12856637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters